Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.RMED · Entity 8648 | 10% owner | April 27, 2020 | April 29, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date April 27, 2020 · Filed April 29, 2020
Jointly reported with Irwin Dean, Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RMEDSEC Table I · non-derivative | Direct | 22,652 |
Reported balance
After 2020-04-27 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-04-27 · Sale · Disposed 44,400 · Balance 22,652 F1: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| RMEDSEC Table I · non-derivative | IndirectBy spouse | 28,697 |
Reported balance
After 2020-04-27 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-04-27 · Sale · Disposed 26,400 · Balance 28,697 F1: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| RMEDSEC Table I · non-derivative | IndirectSee footnote | 2,743,852 |
Reported balance
After 2020-04-28 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-04-28 · Sale · Disposed 60,000 · Balance 2,743,852 F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: Shares held of record by Dean Irwin and Melissa Burstein, as trustees U/T/A June 12, 2017, of which Dean Irwin serves as co-trustee |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018.
F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: Shares held of record by Dean Irwin and Melissa Burstein, as trustees U/T/A June 12, 2017, of which Dean Irwin serves as co-trustee
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2020 Filed Apr 29, 2020 16:56 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | SaleRMED | 60,000 | $1.07 | $64,014.00 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 3 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,743,852 F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held of record by Dean Irwin and Melissa Burstein, as trustees U/T/A June 12, 2017, of which Dean Irwin serves as co-trustee Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 16:56 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | SaleRMED | 26,400 | $1.03 | $27,181.44 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 2 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 28,697 F1 · shares: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 16:56 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | SaleRMED | 44,400 | $1.03 | $45,621.00 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 1 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,652 F1 · shares: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.